Clobot
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Clobot develops software that lets robots navigate autonomously and be managed across a fleet, enabling robots to guide visitors, deliver packages, patrol premises, and automate warehouse or factory tasks.
Its customers are primarily public-sector bodies and businesses that deploy these robot services. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company licenses its core software platforms, CHAMELEON for autonomous navigation and CROMS for multi-robot fleet management, to robot manufacturers, while also delivering end-to-end robot service projects directly to operators.
Summary is AI-generated and may contain errors · figures from DART filings
Clobot in five facts
What does Clobot do?
Clobot develops software that lets robots navigate autonomously and be managed across a fleet, enabling robots to guide visitors, deliver packages, patrol premises, and automate warehouse or factory tasks.
Where is Clobot listed and in which sector?
Clobot (Korean name: 클로봇) trades under KRX code 466100 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Information Technology sector, Software.
How large is Clobot?
Its market capitalisation was US$460.9M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Clobot's latest annual revenue and operating profit?
For fiscal year 2025, Clobot reported revenue of US$31.3M and an operating loss of US$2.4M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 24.0% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on securities held by executives/major shareholdersOct 12
- Report on large shareholdings (5% rule) (abbreviated)Sep 9
- [Amended] Material event report (equity acquisition)
Clobot finalized its acquisition of all 412,428 shares (100%) of Doosan Logistics Solution Co., Ltd. from Doosan Corporation, revising the total acquisition amount down to US$48.8M, the closing cash payment to US$2.45M, and moving the closing date to August 28, 2026.
M&A · Aug 31 · 2 versions - Subscription results of rights offering or equity-linked bonds (voluntary)
Clobot Co., Ltd.'s rights offering drew only 94.68% existing-shareholder subscription (leaving 292,491 forfeited shares), but the subsequent general public offering for those forfeited shares drew 143,321,648 shares in subscriptions -- a 49,000.36% subscription rate -- over August 19-20, 2026.
Capital raise · Aug 21 - Subscription results of rights offering or equity-linked bonds (voluntary)
Clobot's shareholder-allocated rights offering drew subscriptions for 5,202,009 of 5,494,500 planned shares (94.68% subscription rate) as of 2026-08-14, with the resulting 292,491 forfeited shares to be offered to the general public on August 19-20, 2026.
Capital raise · Aug 18 - Rights offering: final issue price set
Clobot Co., Ltd. finalized the issue price for its planned 5,494,500-share common stock rights offering at US$14.59 per share (par value US$0.35), confirmed 2026-08-10, equal to the lower of the first (US$14.59) and second (US$16.92) provisional prices.
Capital raise · Aug 11 - [Amended] Material event report (rights offering)
Clobot updated the terms of a new share issuance to raise US$80.2M, about 15.2% of its market value.
Capital raise · Aug 11 · 4 versions - Ex-rights (rights offering)
Clobot's shares will trade ex-rights from July 6, 2026, with a base price of US$18.03, in connection with its rights offering.
Capital raise · Jul 3 - Rights offering: round 1 issue price set
Clobot set the first issue price for its rights offering at US$13.36 per share for 5,494,500 new common shares (par value US$0.32); the final issue price will be announced on August 11, 2026.
Capital raise · Jul 3 - Supply contract signed (voluntary)
Clobot disclosed a supply contract, worth US$1.36M, about 5.01% of its recent annual revenue, running through Feb 2027.
Supply contract · Jun 9 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Clobot reported consolidated results for FY2025: revenue of US$28.5M (+23.4% year on year), an operating loss of US$2.16M and a net loss of US$1.43M.
Earnings · Feb 12